Discover
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
5.33
2 x 2.91
2 x 5.09
bid
ask
-
0.22
4.05%
2 @ 05:03 PM
5.46 +0.13 (2.43%)
| Ytd | -70.39% | |
| 1y | -88.80% |
5.11
day range
5.47
2.78
52 week range
47.60
| Open | 5.32 | Prev Close | 5.55 | Low | 5.11 | High | 5.47 | Mkt Cap | 25.40M |
| Vol | 29.45K | Avg Vol | 1.36M | EPS | -16.87 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.74 | Short Ratio | 0.25 | Inst. Own | 1.81% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 3.83 | 200-d Avg | 8.07 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 3.95M | ||
| Research and Development Expense | 55.66K | ||
| Selling, General and Administrative Expense | 3.89M | ||
| Operating Income | -3.95M | ||
| Net Income | -3.15M | ||
| Net Income Common Stock | -3.15M | ||
| Net Income Common Stock (USD) | -3.15M | ||
| Consolidated Income | -3.15M | ||
| Earnings per Basic Share | -3.10 | ||
| Earnings per Basic Share (USD) | -3.10 | ||
| Earnings per Diluted Share | -3.10 | ||
| Earning Before Interest & Taxes (EBIT) | -3.15M | ||
| Earning Before Interest & Taxes (USD) | -3.15M | ||
| Weighted Average Shares | 1.02M | ||
| Weighted Average Shares Diluted | 1.02M | ||
| Balance Sheet | |||
| Cash and Equivalents | 90.24K | ||
| Cash and Equivalents (USD) | 90.24K | ||
| Investments | 13.68M | ||
| Investments Non-Current | 13.68M | ||
| Current Assets | 396.35K | ||
| Property, Plant & Equipment Net | 82.63K | ||
| Total Assets | 22.81M | ||
| Debt Current | 82.81K | ||
| Total Debt | 195.16K | ||
| Current Liabilities | 3.48M | ||
| Debt Non-Current | 112.35K | ||
| Total Liabilities | 3.63M | ||
| Accumulated Retained Earnings (Deficit) | -51.60M | ||
| Shareholders Equity | 19.18M | ||
| Shareholders Equity (USD) | 19.18M | ||
| Assets Non-Current | 22.41M | ||
| Total Debt (USD) | 195.16K | ||
| Goodwill and Intangible Assets | 8.65M | ||
| Liabilities Non-Current | 148.10K | ||
| Trade and Non-Trade Payables | 2.79M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 633.45K | ||
| Net Cash Flow from Financing | 5.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -999.71K | ||
| Capital Expenditure | -36.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | -5.40M | ||
| Issuance (Purchase) of Equity Shares | 5.00M | ||
| Net Cash Flow from Investing | -5.43M | ||
| Net Cash Flow from Operations | -567.64K | ||
| Share Based Compensation | -7.51K | ||